Targeting KRAS in colorectal cancer: a bench to bedside review
Colorectal cancer (CRC) is a heterogeneous disease with a myriad of alterations at the
cellular and molecular levels. Kristen rat sarcoma (KRAS) mutations occur in up to 40% of …
cellular and molecular levels. Kristen rat sarcoma (KRAS) mutations occur in up to 40% of …
Non-hematologic toxicity of bortezomib in multiple myeloma: The neuromuscular and cardiovascular adverse effects
E Pancheri, V Guglielmi, GM Wilczynski, M Malatesta… - Cancers, 2020 - mdpi.com
Simple Summary Multiple myeloma (MM) is a still uncurable tumor of mainly elderly patients
originating from the terminally differentiated B cells. Introduction to the treatment of MM …
originating from the terminally differentiated B cells. Introduction to the treatment of MM …
Long-term prevalence of sensory chemotherapy-induced peripheral neuropathy for 5 years after adjuvant FOLFOX chemotherapy to treat colorectal cancer: a …
M Selvy, B Pereira, N Kerckhove, C Gonneau… - Journal of clinical …, 2020 - mdpi.com
(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Little data are
available on the long-term prevalence and consequences of chemotherapy-induced …
available on the long-term prevalence and consequences of chemotherapy-induced …
Prevalence of chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center cross-sectional study
M Selvy, N Kerckhove, B Pereira, F Barreau… - Frontiers in …, 2021 - frontiersin.org
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib
is a neurotoxic anticancer drug responsible for chemotherapy-induced peripheral …
is a neurotoxic anticancer drug responsible for chemotherapy-induced peripheral …
Chemotherapy and peripheral neuropathy
Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …
Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review
Purpose Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common dose-limiting
toxicity of cancer treatment causing functional impairment and impacting quality of life …
toxicity of cancer treatment causing functional impairment and impacting quality of life …
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models
S Magli, GB Rossi, G Risi, S Bertini, C Cosentino… - Frontiers in …, 2020 - frontiersin.org
The development of 3D printable hydrogels based on the crosslinking between chitosan and
gelatin is proposed. Chitosan and gelatin were both functionalized with methyl furan groups …
gelatin is proposed. Chitosan and gelatin were both functionalized with methyl furan groups …
[HTML][HTML] The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy
W Yan, Z Wu, Y Zhang, D Hong, X Dong, L Liu… - Biomedicine & …, 2021 - Elsevier
The proteasome inhibitor bortezomib (BTZ) is a first-line antitumor drug, mainly used for
multiple myeloma treatment. However, BTZ shows prominent toxicity in the peripheral …
multiple myeloma treatment. However, BTZ shows prominent toxicity in the peripheral …
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews
M Mainou, KI Bougioukas, K Malandris, A Liakos… - Annals of …, 2024 - Springer
The present study is an overview of systematic reviews focusing on adverse events of
antimyeloma treatments. It provides a systematic description of adverse events as they are …
antimyeloma treatments. It provides a systematic description of adverse events as they are …
Review article “spotlight on ultrasonography in the diagnosis of peripheral nerve disease: the evidence to date”
A Hannaford, S Vucic, MC Kiernan… - International Journal of …, 2021 - Taylor & Francis
Neuromuscular ultrasound is rapidly becoming incorporated into clinical practice as a
standard tool in the assessment of peripheral nerve diseases. Ultrasound complements …
standard tool in the assessment of peripheral nerve diseases. Ultrasound complements …